CCL2 and essential thrombocythemia: We then asked whether PMF hematopoietic progenitors could be a target of CCL2 by testing the expression of its primary receptor CCR2 on PMF CD34+ and comparing it with CCR2 expression on CD34+ cells from HD, PV/ET and JAK2V617Fpos HEL cells.